In addition, we demonstrate that oncogenic KRASG12V expression together with null mutations in CDKN2A, SMAD4 and TP53 in previously healthy human ductal cells is sufficient to produce lesions resembling human PanINs, but not invasive PDA within the framework of our experiments. The gene discussed is TP53; the disease is Patent ductus arteriosus.